Clifford Chance Advises on Acquisition of Australian Pharmaceutical Company
International law firm Clifford Chance has advised Amdipharm Mercury (AMCo) on its acquisition of Australian pharmaceutical company, Boucher and Muir (BNM). The acquisition of BNM is in line with AMCo’s strategy of international expansion into key territories. In addition to owning rights to a portfolio of specialty and niche medicines, B&M is one of AMCo’s
Clifford Chance Advises on Acquisition of Australian Pharmaceutical Company Read More »